Global Allogeneic Cell Therapy Market Projected to Expand at 10.8% CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Allogeneic Cell Therapy Market Size Likely To Evolve From 2025 Through 2034?

The allogeneic cell therapy market has experienced substantial expansion in recent years. Projections indicate it will grow from $1.08 billion in 2024 to $1.2 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.5%. This growth observed in the past can be attributed to a heightened focus on tailoring donor cell selection and genetic modifications, an increasing global population, a rise in the worldwide burden of chronic diseases, enhanced awareness, and an increase in collaborations for biosimilar development.

The allogeneic cell therapy market is poised for significant expansion in the coming years. It is projected to reach $1.81 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.8%. This anticipated growth throughout the forecast period stems from the increasing requirement for advanced medical treatments, a rising demand for novel allogeneic cell therapies, an escalating number of clinical trials, contributions from an expanding patient population, and rising income levels. Prominent trends for the forecast period include technological advancements, strategic partnerships, collaborations between large companies, mergers and acquisitions, and the introduction of new products.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15976&type=smp

Which Factors And Drivers Are Influencing The Allogeneic Cell Therapy Market In 2025?

The rising incidence of chronic ailments is anticipated to fuel expansion in the allogeneic cell therapy market. A chronic condition is a persistent health issue that usually demands continuous medical care and can impair daily functioning or overall well-being. The widespread occurrence of chronic diseases stems from lifestyle changes, genetic factors, and environmental exposure to chemicals, toxins, and airborne pollutants. Allogeneic cell therapy offers considerable promise for managing numerous chronic conditions by employing healthy donor cells to mend, substitute, or regulate impaired cells or tissues within the patient. As an illustration, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based medicine library, projected that the population aged 50 and above suffering from at least one chronic illness would surge by 99.5% by 2050, escalating from 71.52 million in 2020 to 142.66 million. Consequently, the heightened incidence of chronic illnesses is a key driver for the expansion of the allogeneic cell therapy market.

What Are The Leading Segments Analyzed In The Allogeneic Cell Therapy Market?

The allogeneic cell therapymarket covered in this report is segmented –

1) By Type: Stem Cell Therapies; Non-Stem Cell Therapies

2) By Therapeutic Area: Hematological Disorders; Dermatological Disorders; Other Therapeutic Area

3) By End User: Hospitals; Specialty Clinics; Research Organizations

Subsegments:

1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells); Mesenchymal Stem Cell Therapy (MSC-Based Therapies); Induced Pluripotent Stem Cells (iPSC-Based Therapies); Neural Stem Cell Therapy; Other Stem Cell Therapies

2) By Non-Stem Cell Therapies: T-cell Therapies; Natural Killer (NK) Cell Therapies; Dendritic Cell Therapies; Other Non-Stem Cell Therapies

Which Market Trends Are Creating New Opportunities In The Allogeneic Cell Therapy Industry?

Major companies in the allogeneic cell therapy market are dedicating efforts to developing innovative solutions, such as cell processing platforms, to enhance their market position. Cell processing platforms encompass systems and technologies employed for the preparation and manipulation of cells for therapeutic applications, covering processes like isolation, purification, expansion, modification, and stringent quality control, all aimed at guaranteeing their suitability for clinical use. For instance, in March 2024, Getinge, a Sweden-based healthcare company, partnered with CellRev, a UK-based biotechnology company, to introduce Livit ACE, a platform for continuous cell processing (Adherent Cell Expansion). This innovative platform incorporates advanced automation and bioprocessing technologies, significantly improving the efficiency and scalability of cell production. Its unique attributes include state-of-the-art cell isolation and purification systems that ensure high cell purity and viability, robust expansion capabilities to produce large quantities of therapeutic cells, sophisticated genetic modification tools for precise cell engineering, and rigorous quality control measures to guarantee the safety and efficacy of the cell products.

Which Key Players Are Driving Competition In The Allogeneic Cell Therapy Market?

Major companies operating in the allogeneic cell therapy market are Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, TrakCel Ltd., Promab Biotechnologies Inc., Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Minerva Biotechnologies Corporation, Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/allogeneic-cell-therapy-global-market-report

How Is Allogeneic Cell Therapy Market Demand Varying Across Different Regions?

North America was the largest region in the allogeneic cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Allogeneic Cell Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15976&type=smp

Browse Through More Reports Similar to the Global Allogeneic Cell Therapy Market 2025, By The Business Research Company

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Stem Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cell Therapy Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795